This finding points to resveratrol’s significance in redifferentiation of anaplastic thyroid carcinoma, suggesting that activating Notch1 signaling could be a treatment option for patients with anaplastic thyroid carcinoma. This evidence concerns the gene NOTCH1 and thyroid gland undifferentiated (anaplastic) carcinoma.